AI-generated analysis. Always verify with the original filing.
Aquestive Therapeutics, Inc. announced that Lori J. Braender will step down from her roles as Chief Legal Officer and Chief Compliance Officer effective April 2, 2026, while remaining as Corporate Secretary through at least year-end. Thomas A. Zalewski was appointed as the new Chief Legal Officer and Chief Compliance Officer effective the same date.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 16,
by reference. The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of, or otherwise subject to the liabilit
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Aquestive Therapeutics, Inc. Press Release, dated March 20, 2026 104 Cover Page
Lori J. Braender
Effective: 2026-04-02
Lori J. Braender
Effective: 2026-04-02
Thomas A. Zalewski
Effective: 2026-04-02